AAD vs ASPS/PSTM for Exhibitors
Side-by-side data and our editorial take on which conference is the right exhibit investment for your medical device.
By Buzzbox Media · Last reviewed August 3, 2026
If you exhibit medical devices, AAD and ASPS/PSTM are likely both on your shortlist. Both serve overlapping clinical buyers, but the audience composition, booth economics, and exhibit floor experience differ in ways that materially affect ROI. AAD draws 20,000 attendees with an estimated all-in 10×10 of $8,000-$14,000, read from the published exhibitor prospectus. ASPS/PSTM draws 5,000 attendees with no booth pricing published by the organizer. Below is the side-by-side data plus our editorial take on which conference fits which kind of exhibitor.
| 9.8 AAD | 9.6 ASPS/PSTM | |
|---|---|---|
| Score | ||
| Buzzbox Score | 9.8 (Exceptional) | 9.6 (Exceptional) |
| Event Details | ||
| Dates | March 27-31, 2026 | October 15-18, 2026 |
| Location | Colorado Convention Center, Denver, CO | George R. Brown Convention Center, Houston, TX |
| Scale | mega | large |
| Audience | ||
| Attendees | 20,000 | 5,000 |
| Exhibitors | 350 | 250 |
| Purchasing authority | ~45% | ~60% |
| Effective buyers | 9,000 | 3,000 |
| Costs | ||
| $/sqft | $45 | n/a |
| 10×10 space | $4,500 | n/a |
| All-in estimate | Est. $8,000-$14,000 | n/a |
| Cost per buyer | $1.22 | n/a |
Why exhibit at AAD
The largest annual dermatology meeting in the world, with 20,000+ attendees and 350+ exhibiting companies. If you sell laser systems, energy-based devices, injectables, or dermatologic diagnostics, AAD is the must-attend show where the majority of the US dermatology market assembles in one hall.
Why exhibit at ASPS/PSTM
The largest plastic surgery-specific meeting in the US, with strong purchasing authority from both aesthetic and reconstructive surgeons. Unlike the Aesthetic Meeting, PSTM draws the full breadth of plastic surgery including reconstructive, hand, and craniofacial, making it ideal for surgical instruments, implants, and OR capital equipment, not just cosmetic devices.
Why skip AAD
The priority point system for booth selection heavily favors returning exhibitors, making it hard for first-timers to secure premium locations. The show is enormous, and smaller companies can get lost in the pharma-heavy exhibit hall unless they have a strong activation strategy.
Why skip ASPS/PSTM
If your device is purely cosmetic/aesthetic (injectables, body contouring lasers), the Aesthetic Meeting may deliver a more targeted audience. PSTM attendees skew toward academic and reconstructive surgery, so consumer-facing aesthetics companies may find less buyer intent here.
AAD booth figures are estimates read from its published exhibitor prospectus ↗, not quotes. ASPS/PSTM publishes no booth pricing we can link to, so no cost is listed for it. See the official ASPS/PSTM site ↗ for exhibitor details. Confirm current pricing with each organizer before committing a budget.
Frequently Asked Questions
Does AAD or ASPS/PSTM have more decision makers?
AAD does, on our estimate: roughly 9,000 effective buyers against about 3,000 at ASPS/PSTM. Effective buyers multiplies total attendance by the share of attendees who hold purchasing authority, so AAD works out to about 20,000 attendees at roughly 45% authority, and ASPS/PSTM to about 5,000 at roughly 60%. Both inputs are estimates drawn from organizer reporting and our own exhibitor research, so read the gap as directional rather than exact.
Want to add a third conference to this comparison?
Compare these conferences in our interactive tool →Other conferences you might consider
Buzzbox Media is a medtech marketing agency with over 15 years in medtech. See our conference marketing.